← FDA DRUG APPROVALS

FDA ANDA · ANDA088042

TRIDERM

triamcinolone acetonide

Sponsor: CROWN LABS

APPLICATION
ANDA088042
TYPE
ANDA
ORIGINAL APPROVAL
1984-03-19
LATEST ACTION
2015-01-07
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

TRIDERMPrescription
TRIAMCINOLONE ACETONIDE 0.5% · CREAM · TOPICAL
TRIDERMPrescription
TRIAMCINOLONE ACETONIDE 0.1% · CREAM · TOPICAL
TRIDERMPrescription
TRIAMCINOLONE ACETONIDE 0.025% · CREAM · TOPICAL

Approval history

2015-01-07Labeling · Supplement 5AP
1996-08-14Labeling · Supplement 3AP
1991-07-10Labeling · Supplement 2AP
1990-06-05Labeling · Supplement 1AP
1984-03-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →